MedPath

A Study to Evaluate The Effect of Draksha (Vitis Vinifera Lin) Panak in Dyslipidaemia.

Phase 2/3
Not yet recruiting
Conditions
Other hyperlipidemia. Ayurveda Condition: hrudya ,
Registration Number
CTRI/2021/07/034572
Lead Sponsor
Sane Guruji Arogya Kendra
Brief Summary

This study is open labelled Randomized comparative clinical trial to evaluate the effect of Draksha (vitis vinifera Lin.) Panak for 60 days with Pathya ahara in patients with Dyslipidaemia. The Primary outcome will be on Blood Lipid levels in patients with Dyslipidaemia.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
45
Inclusion Criteria
  • 1.Patient of age group 20 to 50 years,irrespective of their gender, religion.
  • 2.Patients with abnormal Sr. lipid levels are singly, or in the cluster of two or all three.
  • 3.Irrespective of taking lipid lowering drug therapy.
  • 4.Irrespective of family hidtory of Atherosclerotic Cardiovascular Disease (ASCVD), Dyslipidaemia.
  • 5.Patient irrespective of known case of HTN.
Exclusion Criteria
  • 1.Patient with Mrudu koshta.
  • 2.Patient known case of Diabetes Mellitus.
  • 3.pregnant Woman.
  • 4.Patient with known case of Atherosclerotic Cardiovascular Disease/ ischemic heart disease.
  • 5.Patient with operated for heart blockages like PTCA or Bypass surgery.
  • Patient with known congenital heart disease.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
A clinical study to evaluate efficacy of Draksha (vitis vinifera Lin.) Panak in Dyslipidaemia. Parameter of efficacy will be Blood Lipid Profile Reports before and after treatment.The drug will be given for 60 days. Patient will be assessed on 25th day, 30th day, 45th day and 60th day of the treatment.Total duration of the study will be 2 months
Secondary Outcome Measures
NameTimeMethod
A clinical study to evaluate efficacy of Draksha (vitis vinifera Lin.) Panak in Dyslipidaemia. Parameter of efficacy will be Blood Lipid Profile Reports before and after treatment. therefore secondary outcome will relief in sign and symptoms of dyslipidaemiaThe drug will be given for 60 days. Patient will be assessed on 25th day, 30th day, 45th day and 60th day of the treatment.Total duration of the study will be 2 months

Trial Locations

Locations (1)

Sane Guruji Arogya Kendra, Malvadi, Hadapsar

🇮🇳

Pune, MAHARASHTRA, India

Sane Guruji Arogya Kendra, Malvadi, Hadapsar
🇮🇳Pune, MAHARASHTRA, India
Vd Nikhita Nalawade Khabale Patil
Principal investigator
7875874580
nikitakhabalepatil@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.